News Releases

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
5/28/2019
4:05 PM ET
Press Release

Diffusion Pharmaceuticals Inc. Announces Closing of $6.45 Million Offering Priced At-the-Market

5/28/2019

CHARLOTTESVILLE, Va., May 28, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion,” the “Company,” “we,” “our” or “us”) today announced the closing of its previously a...

 Continue Reading
5/24/2019
9:00 AM ET
Press Release

Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement

5/24/2019

CHARLOTTESVILLE, Va., May 24, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion,” the “Company,” “we,” “our” or “us”) today announced that it has entered into a defi...

 Continue Reading
5/23/2019
7:30 AM ET
Press Release

Diffusion Pharmaceuticals Receives Notice of Intention to Grant a Patent Related to Use of TSC in Combination with tPA in Ischemic Stroke from European Patent Office

5/23/2019

Two Additional European Patents Issued

CHARLOTTESVILLE, Va., May 23, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or “the Company”), a cutting-edge...

 Continue Reading
5/9/2019
4:05 PM ET
Earnings Release

Diffusion Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update

5/9/2019

CHARLOTTESVILLE, Va., May 09, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a cutting-edge biotechnology company developing new treatments for life-threatening medical cond...

 Continue Reading
3/20/2019
9:00 AM ET
Earnings Release

Diffusion Pharmaceuticals Reports 2018 Financial Results and Provides Business Update

3/20/2019

CHARLOTTESVILLE, Va., March 20, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a cutting-edge biotechnology company developing new treatments for life-threatening medical co...

 Continue Reading
2/11/2019
4:00 PM ET
Press Release

Poster Presented at International Stroke Conference Describing Diffusion’s On-Ambulance Phase 2 Trial with TSC for Treating Acute Stroke

2/11/2019

CHARLOTTESVILLE, Va., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a cutting-edge biotechnology company developing new treatments for life-threatening medical con...

 Continue Reading
1/3/2019
9:00 AM ET
Press Release

Diffusion Pharmaceuticals Executes Successful NASDAQ Compliance Plan: Company Will Remain Listed on NASDAQ Stock Market

1/3/2019

CHARLOTTESVILLE, Va., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a cutting-edge biotechnology company developing new treatments for life-threatening medical con...

 Continue Reading
Displaying 1 to 7 (of 113 releases)